No takes yet. Share an insight, caveat, or question.
Evidence review reveals early cholinergic disruption in Alzheimer's disease contributes to cognitive deficits and neuropathology, highlighting its potential modulatory role.
Marsel Mesulam (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: